13F filing recap · Q4 2020
What did Fairfax Financial Holdings buy in Q4 2020?
Reported stock-position changes between this filing and the previous one.
Stock value
$2.25B
Positions
59
Estimated turnover
4.5%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
PFEPfizer Inc.$11.08Mreported value+300.9K sharesMRKMerck & Co., Inc.$10.05Mreported value+122.9K sharesIMAXImax Corporation$1.62Mreported value+90.0K sharesBAMBrookfield Corporation$1.44Mreported value+35.0K sharesDENNDenny'S Corporation$1.38Mreported value+94.0K sharesLBRDKLiberty Broadband Corporation$1.01Mreported value+6.4K sharesWGHTQWw International Inc$1.00Mreported value+41.0K sharesUAUnder Armour, Inc.$952.0Kreported value+64.0K sharesCLGXCorelogic Inc$866.0Kreported value+11.2K sharesCBMGCellular Biomedicine Group Inc$158.0Kreported value+8.6K shares